NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 315 filers reported holding NATERA INC in Q2 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,302 | -9.4% | 504 | -0.4% | 0.00% | 0.0% |
| Q2 2023 | $24,622 | -17.4% | 506 | -5.8% | 0.00% | 0.0% |
| Q1 2023 | $29,814 | +38.2% | 537 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $21,571 | +13.5% | 537 | +23.4% | 0.00% | 0.0% |
| Q3 2022 | $19,000 | +26.7% | 435 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $15,000 | -11.8% | 435 | +4.1% | 0.00% | – |
| Q1 2022 | $17,000 | -55.3% | 418 | +1.7% | 0.00% | -100.0% |
| Q4 2021 | $38,000 | 0.0% | 411 | +20.2% | 0.00% | -50.0% |
| Q3 2021 | $38,000 | 0.0% | 342 | +2.7% | 0.00% | 0.0% |
| Q2 2021 | $38,000 | – | 333 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 881,436 | $48,937,327 | 32.36% |
| Kynam Capital Management, LP | 2,918,237 | $162,020,518 | 20.92% |
| Sofinnova Investments, Inc. | 3,100,560 | $172,143,091 | 11.01% |
| Eversept Partners, LP | 2,819,770 | $156,553,630 | 10.92% |
| Eagle Health Investments LP | 784,894 | $43,577,315 | 8.48% |
| Lagoda Investment Management, L.P. | 162,625 | $9,028,940 | 6.42% |
| BEACONLIGHT CAPITAL, LLC | 204,567 | $11,357,560 | 6.00% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $38,875 | 4.86% |
| PERKINS CAPITAL MANAGEMENT INC | 62,700 | $3,481 | 3.28% |
| RTW INVESTMENTS, LP | 2,611,783 | $145,006,192 | 3.02% |